Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Predictive factors of self-medicated analgesic use in Spanish adults: a cross-sectional national study

  • Pilar Carrasco-Garrido1Email author,
  • Ana López de Andrés1,
  • Valentín Hernández Barrera1,
  • Isabel Jiménez-Trujillo1,
  • César Fernandez-de-las-Peñas2,
  • Domingo Palacios-Ceña3,
  • Soledad García-Gómez-Heras4 and
  • Rodrigo Jiménez-García1
BMC Pharmacology and Toxicology201415:36

DOI: 10.1186/2050-6511-15-36

Received: 9 April 2014

Accepted: 3 July 2014

Published: 8 July 2014

Abstract

Background

Analgesics are among the most commonly consumed drugs by the world populations. Within the broader context of self-medication, pain relief occupies a prominent position. Our study was to ascertain the prevalence of self-medication with analgesics among the Spanish population and to identify predictors of self-medication, including psychological disorders, psychological dysfunction, mental health status, and sociodemographic and health-related variables.

Methods

We used individualized secondary data retrieved from the 2009 European Health Interview Survey (EHIS) for Spain to conduct a nationwide, descriptive, cross-sectional pharmacoepidemiology study on self-medication with analgesics among adults (individuals aged at least 16 years) of both genders living in Spain. A total of 7,606 interviews were analysed. The dichotomous dependent variables chosen were the answers “yes” or “no” to the question In the last 2 weeks have you taken the medicines not prescribed for you by a doctor for joint pain, headache, or low back pain?” Independent variables were sociodemographic, comorbidity, and healthcare resources.

Results

A total of 7,606 individuals reported pain in any of the locations (23.7%). In addition, analgesic consumption was self-prescribed in 23.7% (1,481) of these subjects. Forty percent (40.1%) of patients self-medicated for headache, 15.1% for low back pain, and 6.7% for joint pain. The variables significantly associated with a greater likelihood of self-medication of analgesics, independently of pain location were: age 16–39 years (2.36 < AOR < 3.68), higher educational level (1.80 < AOR <2.21), psychological disorders (1.56 < AOR < 1.98), and excellent/good perception of health status (1.74 < AOR < 2.68). In subjects suffering headache, self-prescription was associated with male gender (AOR 2.13) and absence of other comorbid condition (AOR 4.65).

Conclusions

This pharmacoepidemiology study constitutes an adequate approach to analgesic self-medication use in the Spanish population, based on a representative nationwide sample. Self-prescribed analgesic consumption was higher in young people with higher educational level, higher income, smoker, and with psychological disorders and with a good perception of their health status independently of the location of pain.

Background

Pain is a common human experience that is explained through a complex study of people within everyday environments and social context [1, 2]. It is one of the main causes of morbidity worldwide affecting 10% to 30% of the European adult population; however, some studies have reported prevalence up to 50% [37]. In North America, the prevalence rate is 31% [8].

Pain is studied from different viewpoints. Associated psychological aspects can affect the consumption of analgesics. In fact, depression, anxiety and personality traits should be taken into consideration when analyzing how pain is perceived [9, 10]. Self-care is practiced daily throughout by several people around the world. Self-medication is viewed as responsible involvement by private individuals in caring for themselves or members of their family [11]. This circumstance has been accentuated by the growing replacement of prescribed medicines by over-the-counter (OTC) remedies [12, 13].

Pain relief occupies a prominent position within the broader context of self-medication [14, 15]. Analgesics are the most commonly consumed drugs in the world, and it is estimated that millions of people in the United States, Australia, and Europe use OTC analgesics on a daily basis [1618]. A Spanish study using data from the 2003 Spanish National Health Survey showed that, among individuals consuming analgesics, 39.4% were self-medicating [19].

Pain interrupts attention and interferes with daily life. Both psychological and social factors have been shown to predict outcome in individuals with chronic pain. In fact, depression is a common comorbidity, yet it is undiagnosed in clinical practice [20, 21]. Given that psychiatric disorders are better diagnosed by structured interviews as part of the clinical practice, it is difficult to obtain reliable results in population-based studies. Some authors have used the generic SF-36 quality of life questionnaire in order to differentiate between patients with and without psychological disorders [22]. Further, health surveys are significantly commended as they collect valuable information related to musculoskeletal pain, which is not available from most other sources of information.

Therefore, the aims of the current study were: first, to ascertain the prevalence of self-medication with analgesics among the Spanish population; second, to identify variables associated to self-medication, including psychological disorders, mental health status, and socio-demographic and health-related variables.

Methods

We conducted a nationwide, descriptive, cross-sectional epidemiologic study on self-medication among adults (individuals aged at least 16 years) of both genders living in Spain. This study was based on data obtained from the European Health Interview Survey for Spain (2009). As this study was conducted using de-identified public-use databases, it was not necessary to have the approval of an ethics committee.

The 2009 European Health Interview Survey for Spain (EHISS)

The European Health Interview Survey (EHIS) was proposed by the European Commission to European Union Member States to create a health information system through comprehensive and coordinated surveys conducted in the European Statistical System under the responsibility of “Eurostat”. In such a way, all European Union States would share common guidelines for the survey modules (health determinants, health status, health care, background variables) and designs and based on a common questionnaire. The EHIS is implemented every five years, with the first wave completed between 2008 and 2009 [23].

In Spain, the EHIS was conducted by the National Statistics Institute (Instituto Nacional de Estadística, INE) under the aegis of the Spanish Ministry of Health and Social Affairs in 2009. This survey is a computer-aided home-based personal interview including nationwide representative sample of civilian, non-institutionalized population aged ≥ 16 years and residing in primary family dwellings (households) in Spain. Study subjects were selected by means of probabilistic multistage sampling, with the first-stage units being census sections and the second-stage units being primary family dwellings. Details of EHISS methodology are described elsewhere [24]. The data collection period ranged from April 2009 to March 2010. The analysis was performed in January 2013.

Analgesic consumption definition

The dependent variable of the current study was created using the following two questions: “In the last two weeks have you taken those medicines prescribed for you by a doctor for joint pain, headache, or low back pain?”, or, “In the last two weeks have you taken the medicines not prescribed for you by a doctor for joint pain, headache, or low back pain?” An affirmative answer to the first question was considered as “prescribed analgesic use”. An affirmative answer to the second question was classified as “self-medicated analgesic use”. Total analgesic use included those with both prescribed and self-medicated drugs.

Socio-demographic variables, lifestyle habits and co-morbid conditions

The following independent variables were included in the analysis. Main socio-demographic features including sex, age, marital status (married or not married), educational level (classified as no formal education, junior school or high school), occupational status (unemployed, employed or inactive), and monthly income.

Within lifestyle habits, smoking habit differentiated between current smokers or non-smokers. The alcohol consumption was measured using the question “Have you consumed alcoholic drinks in the previous 2 weeks?” Individuals were also asked for: “Do you practice any leisure time physical activity for at least 3 day per week? (Answer: active or inactive) Finally, the body mass index (BMI) was calculated from the self-reported body weight and height. Individuals with a BMI ≥ 30 were classified as obese.

Self-perceived health status was assessed with the following question: “How did you self-perceive your health status over the previous 12 months?” Subjects described health status as excellent, good, fair, poor or very poor. This variable was dichotomized into two: excellent/good or fair/poor/very poor self-perceived health status. Mental health was assessed with 2 indicators extracted from the Short-Form SF-36 quality of life questionnaire: psychological dysfunction and mental health status. Both indicators are obtained through 9 items which are scored from 0 to 100 points, where higher scores represent better mental health [25].

To identify individuals with associated chronic conditions, we used self-reported affirmative answer to the presence of any physician diagnosed concomitant diseases including hypertension, hypercholesterolemia, respiratory disease (asthma and chronic bronchitis), heart disease, diabetes, and cancer. We recorded whether patients had none, 1–2, or > 2 diseases. The presence of depression or anxiety (psychological disorders) was assessed using the following 2 questions: “Have you suffered from depression and/or anxiety the previous 12 months?”, and, “Has your medical doctor confirmed the diagnosis?”

Statistical analysis

Self-medication patterns were identified using descriptive statistics of the main study variables by calculating the prevalence of total use and self-medication with analgesics for joint pain, headache, low back pain, and any pain localization during the years 2009–2010. Pearson χ2 test was used for the bivariate comparison of proportions.

Mean scores were also obtained for those variables from SF-36 (psychological dysfunction and mental health status) by calculating the difference in means between those who consume analgesics and those who did not for each of the pain localizations analyzed in the study, as well as the difference in means between those who consumed prescription analgesics and those who were self-medicated with analgesics for joint pain, headache, low back pain, and any localization.

To estimate the independent effect of the study variables on self-medication with analgesic drugs, we obtained the corresponding adjusted odds ratio (AOR) and the 95% Confidence Interval (95% CI) by means of multivariate logistic regression analysis. All variables showing a significant association in the bivariate analysis were included in the multivariate analysis, along with those variables that were considered relevant according to scientific literature. Four models were generated, as follows: one to identify factors associated with self-medication using analgesic drugs for joint pain; a second model to identify those factors predicting self-medication with analgesic drugs for headache; a third model for self-medication with analgesic drugs for low back pain; and a fourth logistic regression model to identify those factors associated with self-medication with analgesic drugs for pain at any pain localization. Estimates were made using the svy (survey commands) functions of the STATA program (STATA Corp, College Station, Texas, USA), which enabled us to incorporate the sampling design and weights into all statistical calculations (descriptive, χ2, logistic regression). Statistical significance was set at a 2-tailed α < 0.05.

Results and discussion

Our results were based on data obtained from 7,606 subjects who answered the questions regarding consumption of analgesic medication (prescribed or self-medicated) in the 2 weeks immediately preceding the survey for any of the localizations analyzed. The sample represented 31.8% of subjects interviewed in the EHISS. Table 1 shows data on total analgesic consumption (with or without medical prescription) for joint pain headache, and low back pain and for any localization, according to socio-demographic characteristics, lifestyle, and health-related study variables. The results showed that 19.9% of the population consumed analgesics for low back pain, 12.6% for joint pain, and 10.9% for headache. The prevalence of consumption for pain at any localization was 39.8% for women and 23.5% for men (P < 0.05). Values for the consumption of analgesics were significantly higher when subjects were aged >65 years, had >2 chronic conditions, a chronic mental illness (anxiety and depression) or worse self-rated health status (P < 0.05).
Table 1

Prevalence of analgesic consumption (prescribed and self-medicated) for joint pain, headache, low back pain and any pain localization in Spanish adult according to socio-demographic variables, lifestyle, and health profile

 

Analgesic consumption for joint pain

Analgesic consumption for headache

Analgesic consumption for low back pain

Any localization

N

%

N

%

N

%

N

%

Age*+Ɨǂ

16-39

176

2.3

738

10.6

1025

14.5

1662

23.4

40-64

1232

12.8

1086

10.9

1963

20.7

3058

32.6

>65

2009

33.5

590

9.6

1807

29.3

2886

47.4

Sex*+Ɨ

Male

820

7.2

688

7.2

1532

14.4

2445

23.5

Female

2597

17.9

1726

14.5

3263

25.1

5161

39.8

Marital status*Ɨǂ

Not married

1641

10.8

1104

10.8

2224

18.8

3519

29.9

Married

1776

14.0

1310

11.0

2571

20.7

4087

33.3

Educational level*+Ɨǂ

No formal education

1353

33.2

488

12.4

1306

32.1

1993

49.1

Junior school

1158

17.7

549

9.6

1291

21.4

2093

34.8

High school

906

6.2

1377

11.1

2198

16.6

3520

26.8

Occupational status*+Ɨǂ

Unemployed

209

8.44

269

11.58

446

18.80

671

27.97

Employed

866

6.99

1205

10.91

1952

16.97

3155

27.59

Inactive

2342

23.61

940

10.73

2397

25.15

3780

40.26

Monthly income*Ɨǂ

<850€

932

22.2

417

12.0

999

26.1

1540

40.3

850-1400€

875

15.8

520

11.0

1180

22.6

1786

34.6

>1400€

1094

9.6

1100

11.0

1935

18.5

3111

29.9

Smoking habit*+Ɨǂ

Non smoker

2935

14.9

1747

10.6

3683

20.8

5860

33.2

Smoker

482

7.1

667

11.8

1112

17.7

1746

28.4

Alcohol consumption*+Ɨǂ

No

2552

12.9

1863

11.9

3572

20.6

5648

33.0

Yes

610

9.6

434

8.2

931

16.1

1541

26.7

Physical activity*Ɨǂ

Inactive

2167

15.1

1340

10.9

2891

22.0

4484

34.3

Moderate

1250

10.1

1074

10.9

1904

17.7

3122

29.3

Body Mass Index Kg/sq.m*Ɨǂ

<30

2148

10.3

1831

10.8

3392

18.4

5418

29.7

≥30

850

22.1

407

12.1

952

26.4

1491

41.2

Self-assessment of health status*+Ɨǂ

Very good/Good

859

4.6

1302

8.8

2079

12.9

3632

22.7

Fair/Poor/Very poor

2558

35.5

1112

17.1

2716

39.7

3974

57.7

Number of chronic conditions*+Ɨǂ

None

1839

9.0

1631

10.1

3035

17.3

4961

28.3

1-2

1367

23.0

691

13.4

1550

27.1

2360

42.2

>2

211

44.9

92

18.7

210

44.7

285

60.0

Psychological disorders*+Ɨǂ

No

2361

10.1

1784

9.6

3580

17.4

5911

28.8

Yes

1056

31.8

630

21.3

1215

38.4

1695

54.1

Psychological dysfunction*+Ɨǂ (mean. se) [mean difference]

64.3 (0.5)

[-14.4]

68.2 (0.6)

[-9.88]

67.9 (0.4)

[-11.4]

69.8 (0.3)

[-10.48]

Positive mental health*+Ɨǂ (mean. se) [mean difference]

50.6 (0.5)

[-20.3]

57.5 (0.6)

[-2.18]

56.2 (0.4)

[-15.1]

58.6 (0.3)

[-14.18]

TOTAL

3417

12.6

2414

10.9

4795

19.9

7606

31.8

European Health Interview Survey (EHIS, 2009).

*Analgesic consumption for joint pain, +Analgesic consumption for headache.

ƗAnalgesic consumption for low back pain, ǂTotal analgesic consumption for any localization.

When pain location was analyzed, analgesic consumption was higher in women than men, individuals with >2 chronic conditions, subjects with psychological disorders, and those subjects reporting fair/poor/very poor health status (P < 0.05). It is noteworthy that consumption of analgesics was also higher in smokers and drinkers compared to non-smokers and no drinkers (P < 0.05). Table 1 summarizes the average scores for psychological dysfunction and mental health status. Subjects exhibiting joint pain who consume analgesics had the lowest scores in both domains of the SF-36.

Analgesic drug consumption was self-prescribed in 23.7% (1,481) of the sample. Table 2 shows the results of the 4 analyses performed to determine the proportion of analgesic self-medication for each of pain localizations according to socio-demographic characteristics, lifestyle and health-related variables. Men self-medicated their analgesic consumption than women (P < 0.05) and self-medication was significantly higher in the population aged 16–39 years than in remaining age groups (P < 0.05). Analgesic self-medication was more frequent in smokers and drinkers than in non-smokers and those subjects who not drinking. Additionally, more over-the-count medication was consumed by subjects reporting excellent/good health status and no chronic diseases (P < 0.05).
Table 2

Proportion of self-prescribed analgesic medication for joint pain, headache, low back pain and any localization in Spanish adult according to socio-demographic variables, lifestyle, health profile

 

Self-medication for joint pain

Self-medication for headache

Self-medication for low back pain

Self-medication for any localization

N

%

N

%

N

%

N

%

Age*+Ɨǂ

16-39

42

19.8

406

57.2

270

28.0

655

41.5

40-64

106

8.8

370

37.2

253

13.7

664

23.6

>65

61

3.2

49

8.1

68

4.1

162

5.7

Sex+Ɨǂ

Male

58

7.5

349

55.2

225

17.0

587

27.8

Female

151

6.4

476

32.8

366

14.1

894

21.3

Marital status+Ɨǂ

Not married

96

6.7

382

45.2

289

19.0

697

28.1

Married

113

6.7

443

36.2

302

12.4

784

20.6

Educational level*+Ɨǂ

No formal education

38

2.9

47

11.3

52

4.6

115

6.4

Junior school

59

5.4

135

29.5

84

7.6

255

14.4

High school

112

12.7

643

50.7

455

23.2

1111

35.2

Occupational status*+Ɨǂ

Unemployed

16

8.15

98

36.62

58

14.10

151

23.20

Employed

95

10.05

548

49.85

393

21.39

948

32.76

Inactive

98

4.83

179

24.54

140

8.26

382

13.32

Monthly income*+Ɨǂ

<850€

28

3.1

69

21.2

53

6.4

139

11.4

850-1400€

42

4.9

152

33.5

122

11.1

282

18.0

>1400€

96

9.1

455

45.7

342

19.8

815

29.3

Smoking habit*+Ɨǂ

Non smoker

159

5.8

506

34.3

370

12.9

946

19.8

Smoker

50

11.3

319

53.0

221

21.7

535

34.9

Alcohol consumption+Ɨǂ

No

146

6.2

605

39.0

428

15.1

1075

23.8

Si

54

9.2

209

52.3

147

18.7

375

28.0

Physical activity*+Ɨǂ

Inactive

108

5.1

408

37.0

287

12.7

736

20.3

Moderate

101

9.1

417

43.2

304

18.2

745

27.8

Body Mass Index Kg/sq.m*+Ɨǂ

<30

157

7.8

699

43.6

491

17.1

1238

27.0

≥30

34

4.3

95

27.6

71

8.8

175

13.9

Self-assessment of health status*+Ɨǂ

Very good/Good

106

12.8

690

56.7

466

25.3

1173

36.2

Fair/Poor/Very poor

103

4.5

135

15.9

125

5.7

308

9.7

Number of chronic conditions*+Ɨǂ

None

153

9.4

686

47.1

473

18.6

1206

28.7

1-2

53

3.7

136

25.3

112

8.9

263

13.9

>2

3

1.4

3

3.3

6

2.8

12

4.2

Psychological disorders t*+Ɨǂ

No

168

7.9

751

47.9

521

17.6

1326

27.0

Si

41

3.8

74

13.6

70

6.8

155

10.6

Psychological dysfunction+ǂ (mean. se) [mean difference]

69.80 (2.1)

[5.8]

76.94 (0.8)

[14.6]

74.41 (1.0)

[7.7]

76.14 (0.6)

[8.3]

Positive mental health*+ǂ (mean. se) [mean difference]

56.76 (2.5)

[6.6]

67.55 (0.8)

[16.9]

65.54 (1.1)

[11.0]

66.56 (0.6)

[10.4]

TOTAL

209

6.7

825

40.1

591

15.1

1481

23.7

European Health Interview Survey (EHIS, 2009).

*Self-medication for joint pain, +Self-medication for headache.

ƗSelf-medication for low back pain, ǂSelf-medication for any localization.

When analgesic self-medication was analyzed by location, those experiencing headaches exhibited higher self-prescription (40.1%) than those suffering low back pain (15.1%) or joint pain (6.7%). The frequency of self-medication was higher in men than in women, in those without other chronic condition or without psychological disorders, and in those subjects reporting excellent/good health status (P < 0.05). The highest values for self-medication were always recorded for individuals suffering from headaches.

Table 2 also shows the average scores obtained for psychological dysfunction and mental health status for use of analgesics without prescription. Self-medication with analgesics for joint pain was the variable with the lowest scores in both domains of the SF-36.

The results of the multivariate logistic regression analysis (adjusted odd ratio) to identify predictors of self-medication with analgesics are summarized in Table 3. The variables that were significantly associated with a greater likelihood of self-medication of analgesics for joint pain were age (aged 16–39 years, OR 3.16 95% CI 1.75-5.71), high educational level (OR 2.21, 95% CI 1.31-3.71), psychological disorders (OR 1.56, 95% CI 1.01-2.46), and excellent/good perception of health status (OR 1.74, 95% CI 1.74-2.49). In subjects suffering headache, analgesic self-prescription was associated with age (aged 16–39 years, OR 3.68, 95% CI 2.25-6.03), male gender (OR 2.13, 95% CI 1.66-2.73) and higher educational level (OR 1.87, 95% CI 1.09-3.19), absence of other comorbid condition (OR 4.65, 95% CI 1.43-15.06), psychological disorders (OR 1.98, 95% CI 1.37-2.88), and excellent/good perception of health status (OR 2.38, 95% CI 1.74-3.26). Finally, the variables associated with a greater likelihood of self-medication for low back pain were age (aged 16–39 years OR 2.36, 95% CI 1.54-3.62), high educational level (OR 1.80, 95% CI 1.15-2.82), to be not married (OR 1.44, 95% CI 1.11-1.87), high monthly income (OR 1.70, 95% CI 1.14-2.54), smoking (OR 1.28, 95% CI 1.01-1.66), psychological disorders (OR 1.61, 95% CI 1.11-2.32) and excellent/good perception of health status (OR 2.68, 95% CI 1.97-3.65).
Table 3

Factors associated with analgesic self-medication among consumers with joint pain, headache, low back pain and any localization in Spanish adult

 

Self-medication for joint pain

Self-medication for headache

Self-medication for low back pain

Self-medication for any localization

AOR, 95% CI

AOR, 95% CI

AOR, 95% CI

AOR, 95% CI

Age

>65

1

1

1

1

40-64

1.78 (1.18-2.70)

2.55 (1.63-3.99)

1.67 (1.12-2.47)

2.38 (1.82-3.09)

16-39

3.16 (1.75-5.71)

3.68 (2.25-6.03)

2.36 (1.54-3.62)

3.71 (2.77-4.97)

Sex

Female

1

1

1

 

Male

NS

2.13 (1.66-2.73)

NS

NS

Educational level

No formal education

1

1

1

1

Junior school

1.37 (0.81-2.33)

1.46 (0.85-2.53)

1.01 (0.62-1.62)

1.29 (0.93-1.80)

High school/University

2.21 (1.31-3.71)

1.87 (1.09-3.19)

1.80 (1.15-2.82)

1.89 (1.37-2.62)

Marital status

Married

1

1

1

 

Not married

NS

NS

1.44 (1.11-1.87)

NS

Monthly income

<850€

1

1

1

1

850-1400€

NS

NS

1.24 (0.82-1.89)

1.03 (0.77-1.38)

>1400€

NS

NS

1.70 (1.14-2.54)

1.33 (1.01-1.75)

Smoking habit

Non smoker

1

1

1

1

Smoker

NS

NS

1.28 (1.01-1.66)

1.34 (1.12-1.60)

Self-assessment of health status

Fair/Poor/Very poor

1

1

1

1

Very good/Good

1.74 (1.22-2.49)

2.38 (1.74-3.26)

2.68 (1.97-3.65)

2.24 (1.81-2.78)

Number of chronic conditions

>2

1

1

1

1

1-2

NS

3.45 (1.05-11.32)

NS

NS

None

NS

4.65 (1.43-15.06)

NS

NS

Psychological disorders

No

1

1

1

1

Yes

1.56 (1.01-2.46)

1.98 (1.37-2.88)

1.61 (1.11-2.32)

1.62 (1.24-2.11)

European Health Interview Survey (EHISS, 2009) for Spain.

Data are expressed as adjusted odds ratio (AOR) and 95% confidence intervals (95% CI).

NS: non-significant association.

When analyzed the variables associated with self-prescription of consumption of analgesics for the presence of pain in any localization, 6 variables were present: aged 16–39 years (OR 3.71, 95% CI 2.77-4.97), high educational level (OR 1.89, 95% CI 1.37-2.62), high monthly income (OR 1.33, 95% CI 1.01-1.75), smoking (OR 1.34, 95% CI 1.12-1.60), psychological disorders (OR 2.24, 95% CI 1.81-2.78), and excellent/good perception of health status (OR 1.62, 95% CI 1.24-2.11).

Analgesic drugs are worldwide used and are justified and necessary in cases of intense and frequent pain [14]. The results of our study showed that 23.7% of Spanish adults who consume analgesic medication use OTC drugs. Our data is higher than the 13.6% found in Finland [26], substantially lower than the 55% use of OTC analgesics found in Australian adults [15] but similar than in American adults (33%) [18]. It seems that self-prescription of analgesic drugs, i.e., OTC use is highly prevalent in populations across the world.

A common denominator associated with OTC analgesic drug consumption is the influence of gender. Although some studies using similar methodology than our study reported a higher probability of self-prescribed analgesic drug consumption in women [18, 27, 28], gender differences could be related to a higher prevalence of headaches in women since headaches are associated with greater consumption of both prescribed and OTC analgesics [29, 30]. Nevertheless, Krymchantowski et al. found that men suffering chronic daily headache exhibited higher medication use than women [31]. It is possible that gender differences in self-prescribed analgesic consumption are related to several factors including specific co-morbid conditions and socio-cultural factors.

We found that subjects aged 19 to 39 years were almost 4 times as likely to use OTC analgesics for any pain location as elderly people. Current results also agree with previous studies. Stosic et al. showed a higher self-prescribed analgesic consumption and use of OTC drugs in Australian adults younger than 54 years old compared to those older than 55 years [15]. Wilcox et al. reported that American adults in the forties had a higher OTC analgesic consumption [18]. Current and previous results suggest that OTC drugs seem to be self-prescribed in a greater manner in the mid-age of the life, probably related to higher prevalence of pain syndromes and higher educational level. In fact, our results revealed that individuals taking OTC analgesics were young and highly educated (university level). Spanish university graduates were twice as likely to take OTC drug consumption as those with lower educational level. Klemenc-Ketis et al. found that 92% of Slovenian university students reported the use of self-medication [28]. These results agree with several published studies where OTC consumption was also associated with higher educational level [19, 32, 33]. Self-medication is more common among healthcare professionals (e.g. physicians, nurses, and pharmacists) than in the general population [34, 35]. This can be related to the fact that healthcare professionals have university studies in almost all countries.

Further, a higher level of education can be related to a higher monthly income. When variable monthly income was analyzed, the results showed that subjects earning more than €1400 per month were more likely to take OTC analgesics, especially for back pain. These data are consistent with those reported in a recent study conducted in American adults where individuals with lower income were less likely to consume OTC non-steroidal anti-inflammatory drugs than those subjects with a higher income [33]. It is possible that a higher educational level involves higher monetary income and both variables are related to greater self-prescription consumption for pain.

Our results showed that smokers were more likely to self-medicate than the non-smoker population. This finding was similar to that previously reported by Hagen et al. in Norwegian adults who observed that smokers exhibited double risk of suffering from medication overuse headache [36]. Although experimental studies support that nicotine has analgesic properties, epidemiological evidence suggests that smoking is a risk factor for chronic pain [37].

Other factors associated with self-prescription of analgesic consumption were the absence of com-morbid conditions, only for those subjects suffering from headaches and excellent/good perception of health status. Previous studies had shown that people with chronic diseases or poor perception of health status are more likely to use analgesic medication [14, 26, 38] which is in accordance with our results. This observation may be related to cultural attitudes to pain [1] or the fact that individuals who self-medicate visit their doctor less often since their pain is less severe. This would be of particular interest in head pain, since headaches of lower/mild intensity can be usually controlled with analgesics. In fact, analgesics are usually consumed by subjects with sporadic pain symptoms. However, unnecessary analgesic use should be avoided since some drugs imply specific risks and, in the case or headaches, can produce medication overuse headache. The biggest challenge for health care professionals remains the provision of adequate pain management on an individual basis [24].

It is well accepted that pain is associated with psychological factors, particularly depression. Anxiety and depression have received the main attention, mostly in relation to recurrence and chronic pain in individuals with low back pain due to its relationship with physical disability and work absenteeism [9, 39]. Our results showed a statistically significant association between the presence of psychological disorders (assessed with the SF-36 questionnaire) and self-medication for all the types of pain analyzed, although the strongest association was found in individuals suffering from headaches. Our results are in line with those previously found in Swedish people in who chronic headache was more prevalent in subjects who overused analgesics (39.8%) than in those who did not (18%) [40]. This study also observed that depression was significantly associated factor for analgesic overuse in general (OR 3.52, 1.46-8.52) [40].

In this context, community pharmacists are important members of health-care team. The pharmacists are probably the health professionals who are closest and most accessible to the patients and the general population. Their opinions related to health education have an important impact on the health of the population [41, 42].

Although strengths of our study include large sample size, a randomly selected population, the employment of standardized survey, and training of the data collectors; there are also a number of possible limitations. First, since we used data from a cross-sectional survey, we cannot determine cause and effect relationships between the variables associated with self-prescribed medication use. Second, the conclusions drawn are difficult to generalize, because the survey has not been validated for drug use. Third, information obtained on interviews is subjective and may be subject to recall errors or a tendency of subjects to give socially desirable responses in the interviews. In addition, several of the data obtained from the interviews were self-reported which can induce a bias and, therefore, the prevalence of self-medication may be underestimated. Another possible limitation is that the survey rather than identifying specific active ingredients, it identifies groups of medications for specific diseases. Nonetheless, health surveys are significantly commended as they collect valuable information related to musculoskeletal pain problems, which is not available from most other sources of information.

Conclusions

This pharmacoepidemiology study constitutes an adequate approach to analgesic self-medication use in the Spanish population, based on a representative nationwide sample. Our study found that 23.7% of Spanish adults use self-prescribed analgesic drug consumption to treat their pain with the highest incidence in headache (40.1%). We also observed that analgesic consumption without prescription seems to be higher in young people with higher educational level, higher monthly income, and smoker. In addition, subjects with psychological disorders and with a good perception of their health status also self-prescribed analgesic drugs. Further, self-prescribed analgesic consumption for headache was more frequent in men without co-morbid chronic diseases.

Declarations

Acknowledgments

This study forms part of a project funded by the Fondo de Investigaciones Sanitarias (FIS) of the Carlos III Institute of Public Health (reference PI13/00369).

Authors’ Affiliations

(1)
Department of Preventive Medicine and Public Health, Rey Juan Carlos University
(2)
Department of Physical Therapy, Occupational Therapy, Rehabilitation and Physical Medicine, Rey Juan Carlos University
(3)
Department of Nursing, Rey Juan Carlos University
(4)
Department of Human Histology and Pathological Anatomy, Rey Juan Carlos University

References

  1. Eccleston C: A normal psychology of everyday pain. Int J Clin Pract Suppl. 2013, 178: 47-50.View ArticlePubMedGoogle Scholar
  2. Langford RM: Pain management today-what have we learned?. Clin Rheumatol. 2006, 25: S2-S8.View ArticlePubMedGoogle Scholar
  3. Langley P: The prevalence, correlates and treatment of pain in the European Union. Curr Med Res Opin. 2011, 27: 463-480.View ArticlePubMedGoogle Scholar
  4. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D: Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006, 10: 287-333.View ArticlePubMedGoogle Scholar
  5. Leijon O, Wahlström J, Mulder M: Prevalence of self-reported neck-shoulder-arm pain and concurrent low back pain or psychological distress: time-trends in a general population, 1990–2006. Spine. 2009, 34: 1863-1868.View ArticlePubMedGoogle Scholar
  6. Fricker J: Pain in Europe report. Research project by NFO Worldgroup, Mundipharma International Limited, Cambridge, UK. 2003, [available] http://www.paineurope.com/painsurveys/pain-in-europe-survey/publication-for-download.html Google Scholar
  7. Harker J, Reid KJ, Bekkering GE, Kellen E, Bala MM, Riemsma R, Worthy G, Misso K, Kleijnen J: Epidemiology of chronic pain in Denmark and Sweden. Pain Res Treat. 2012, 2012: 371248-PubMedPubMed CentralGoogle Scholar
  8. Strine TW, Hootman JM: US national prevalence and correlates of low back and neck pain among adults. Arthritis Rheum. 2007, 57: 656-665.View ArticlePubMedGoogle Scholar
  9. Mok LC, Lee IF: Anxiety, depression and pain intensity in patients with low back pain who are admitted to acute care hospitals. J Clin Nurs. 2008, 17: 1471-1480.View ArticlePubMedGoogle Scholar
  10. Haggman S, Maher CG, Refshauge KM: Screening for symptoms of depression by physical therapists managing low back pain. Phys Ther. 2004, 84 (12): 1157-1166.PubMedGoogle Scholar
  11. Ryan A, Wilson S, Taylor A, Greenfield S: Factors associated with self-care activities among adults in the United Kingdom: a systematic review. BMC Public Health. 2009, 9: 96-View ArticlePubMedPubMed CentralGoogle Scholar
  12. Hanna LA, Hughes CM: Public’s views on making decisions about over-the-counter medication and their attitudes towards evidence of effectiveness: a cross-sectional questionnaire study. Patient Educ Couns. 2011, 83: 345-351.View ArticlePubMedGoogle Scholar
  13. Häussinger C, Ruhl UE, Hach I: Health beliefs and over-the-counter product use. Ann Pharmacother. 2009, 43: 1122-1127.View ArticlePubMedGoogle Scholar
  14. Sawyer P, Bodner EV, Ritchie CS, Allman RM: Pain and pain medication use in community-dwelling older adults. Am J Geriatr Pharmacother. 2006, 4: 316-324.View ArticlePubMedGoogle Scholar
  15. Stosic R, Dunagan F, Palmer H, Fowler T, Adams I: Responsible self-medication: perceived risks and benefits of over-the-counter analgesic use. Int J Pharm Pract. 2011, 19: 236-245.View ArticlePubMedGoogle Scholar
  16. Hersh EV, Pinto A, Moore PA: Adverse drug interactions involving common prescription and over-the-counter analgesic agents. Clin Ther. 2007, 29: 2477-2497.View ArticlePubMedGoogle Scholar
  17. Roumie CL, Griffin MR: Over-the-counter analgesics in older adults: a call for improved labelling and consumer education Drugs Aging. 2004, 21: 485-498.Google Scholar
  18. Wilcox CM, Cryer B, Triadafilopoulos G: Patterns of use and public perception of over-the-counter pain relievers: focus on nonsteroidal antiinflammatory drugs. J Rheumatol. 2005, 32: 2218-2224.PubMedGoogle Scholar
  19. Carrasco-Garrido P, Jiménez-García R, Barrera-Hernandez V, Gil de Miguel A: Predictive factors of self-medicated drug use among the Spanish adult population. Pharmacoepidemiol Drug Saf. 2008, 17: 193-199.View ArticlePubMedGoogle Scholar
  20. Walsh TL, Homa K, Hanscom B, Lurie J, Sepulveda MG, Abdu W: Screening for depressive symptoms in patients with chronic spinal pain using the SF-36 Health Survey. Spine J. 2006, 6: 316-320.View ArticlePubMedGoogle Scholar
  21. Keeley P, Creed F, Tomenson B, Todd C, Borglin G, Dickens C: Psychosocial predictors of health-related quality of life and health service utilisation in people with chronic low back pain. Pain. 2008, 135: 142-150.View ArticlePubMedGoogle Scholar
  22. Oswald J, Salemi S, Michel BA, Sprott H: Use of the short-form-36 health survey to detect a subgroup of fibromyalgia patients with psychological dysfunction. Clin Rheumatol. 2008, 27: 919-921.View ArticlePubMedGoogle Scholar
  23. European Commission: Eurostat. European health interview survey (EHIS). Accessed: April 5, 2013. Available at: http://epp.eurostat.ec.europa.eu/portal/page/portal/microdata/european_health_interview_survey
  24. Insituto Nacional de Estadistica: Encuesta Europea de Salud para España. Available at: http://www.ine.es/metodologia/t15/t153042009.pdf. Accessed: April 5, 2013
  25. Ware JE, The SCD, MOS: 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992, 30: 473-483.View ArticlePubMedGoogle Scholar
  26. Turunen JH, Mäntyselkä PT, Kumpusalo EA, Ahonen RS: Frequent analgesic use at population level: prevalence and patterns of use. Pain. 2005, 115: 374-381.View ArticlePubMedGoogle Scholar
  27. Carrasco-Garrido P, Hernández-Barrera V, López de Andrés A, Jiménez-Trujillo I, Jiménez-García R: Sex-differences on self-medication in Spain. Pharmacoepidemiol Drug Saf. 2010, 19: 1293-1299.View ArticlePubMedGoogle Scholar
  28. Klemenc-Ketis Z, Hladnik Z, Kersnik J: A cross sectional study of sex differences in self-medication practices among university students in Slovenia. Coll Antropol. 2011, 35: 329-334.PubMedGoogle Scholar
  29. Colás R, Muñoz P, Temprano R, Gómez C, Pascual J: Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology. 2004, 62: 1338-1342.View ArticlePubMedGoogle Scholar
  30. Chilet-Rosell E, Ruiz-Cantero MT, Sáez JF, Alvarez-Dardet C: Inequality in analgesic prescription in Spain. A gender development issue. Gac Sanit. 2013, 27: 135-142.View ArticlePubMedGoogle Scholar
  31. Krymchantowski AV, Moreira PF: Clinical presentation of transformed migraine: possible differences among male and female patients. Cephalalgia. 2001, 21: 558-566.View ArticlePubMedGoogle Scholar
  32. Al-Windi A, Elmfeldt D, Svärdsudd K: Determinants of drug utilisation in a Swedish municipality. Pharmacoepidemiol Drug Saf. 2004, 13 (2): 97-103.View ArticlePubMedGoogle Scholar
  33. Delaney JA, Biggs ML, Kronmal RA, Psaty BM: Demographic, medical, and behavioral characteristics associated with over the counter non-steroidal anti-inflammatory drug use in a population-based cohort: results from the Multi-Ethnic Study of Atherosclerosi. Pharmacoepidemiol Drug Saf. 2011, 20: 83-89.View ArticlePubMedGoogle Scholar
  34. Montgomery AJ, Bradley C, Rochfort A, Panagopoulou E: A review of self-medication in physicians and medical students. Occup Med. 2011, 61: 490-497.View ArticleGoogle Scholar
  35. Klemenc-Ketis Z, Hladnik Z, Kersnik J: Self-medication among healthcare and non-healthcare students at University of Ljubljana, Slovenia. Med Princ Pract. 2010, 19: 395-401.View ArticlePubMedGoogle Scholar
  36. Hagen K, Linde M, Steiner TJ, Stovner LJ, Zwart JA: Risk factors for medication-overuse headache: an 11-year follow-up study. The Nord-Trøndelag Health Studies. Pain. 2012, 153: 56-61.View ArticlePubMedGoogle Scholar
  37. Weingarten TN, Podduturu VR, Hooten WM, Thompson JM, Luedtke CA, Oh TH: Impact of tobacco use in patients presenting to a multidisciplinary outpatient treatment program for fibromyalgia. Clin J Pain. 2009, 25: 39-43.View ArticlePubMedGoogle Scholar
  38. Nielsen MW, Hansen EH, Rasmussen NK: Prescription and non-prescription medicine use in Denmark: association with socio-economic position. Eur J Clin Pharmacol. 2003, 59: 677-684.View ArticlePubMedGoogle Scholar
  39. Schiphorst Preuper HR, Reneman MF, Boonstra AM, Dijkstra PU, Versteegen GJ, Geertzen JH, Brouwer S: Relationship between psychological factors and performance-based and self-reported disability in chronic low back pain. Eur Spine J. 2008, 17: 1448-1456.View ArticlePubMedPubMed CentralGoogle Scholar
  40. Schmid CW, Maurer K, Schmid DM, Alon E, Spahn DR, Gantenbein AR, Sandor PS: Prevalence of medication overuse headache in an interdisciplinary pain clinic. J Headache Pain. 2013, 14: 4-View ArticlePubMedPubMed CentralGoogle Scholar
  41. Caamaño F, Alvarez R, Khoury M: The community pharmacists and their practice as health care providers. Gac Sanit. 2008, 22 (4): 385-View ArticlePubMedGoogle Scholar
  42. Hanna LA, Hughes CM: Pharmacists’ attitudes towards an evidence-based approach for over-the-counter medication. Int J Clin Pharm. 2012, 34 (1): 63-71.View ArticlePubMedGoogle Scholar
  43. Pre-publication history

    1. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/2050-6511/15/36/prepub

Copyright

© Carrasco-Garrido et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement